Research Developments in Atopic Dermatitis (AAD 2020 and AAAAI 2020)

1.75 CME
105 MINS
$0 FEE
SAVE
cme

Overview

Provider Statement

Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice. They also discuss new evidence related to the burden of disease experienced by patients and caregivers and intriguing evidence pointing to the heterogeneity of atopic dermatitis.


Support Statement

This activity is supported by an independent educational grant from Pfizer Inc. 


Target Audience

This activity was developed for Dermatologists, pediatric dermatologists, allergists, and other clinicians who manage patients with atopic dermatitis.


Learning Objective

At the conclusion of this activity, participants should be better able to:

  • Summarize the latest research developments in the pharmacologic treatment of atopic dermatitis with new and emerging agents
  • Describe how new data and recommendations can impact clinical practices to improve care
  • Incorporate evidence-based research into clinical practice

Faculty

Steven Feldman, MD, PhD
Department of Dermatology
Wake Forest School of Medicine
Winston-Salem, North Carolina

Alan B. Fleischer, Jr, MD
Professor and Residency Program Director
Department of Dermatology
University of Cincinnati College of Medicine
Cincinnati, Ohio


Reviewers

Greg Scott, RPH, PharmD (medical writer)
Eugene Cullen, MD (peer reviewer)


Accreditation

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


How to Participate in This Activity and Obtain CME Credit

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the materials, reflecting on its implications in your practice, and completing the assessment component.


Disclosures

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Steven Feldman, MD, PhD

  • Research support: Abbvie, Amgen, Celgene, Galderma Laboratories, L.P., Janssen, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, Sanofi, Taro
  • Consultant: Abbvie, Alvotech, Advance Medical, Caremark, Amgen, Celgene, Galderma Laboratories, L.P., Gerson Lehrman Group, Guidepoint Global, Janssen, Kikaku, Leo, Pharma Inc., Lilly, Merck & Co., Inc., Mylan, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, Sanofi, Sienna, Sun Pharma, Suncare Research, Ortho Dermatology, Xenoport
  • Speakers bureau: Abbvie, Amgen, Celgene, Janssen, Leo Pharma Inc., Lilly, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, Sanofi, Sun Pharma, Taro, Ortho Dermatology
  • Royalties:  Informa, UpToDate, Xlibris
  • Stockholder: Causa Technologies, Medical Quality Enhancement Corporation

Alan B. Fleischer, Jr, MD

  • Research support: Galderma, Trevi
  • Consultant: Boehringer Ingelheim, Incyte, Qurient, Syneos

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

The following have no significant relationship to disclose:
Greg Scott, RPH, PharmD (medical writer)
Eugene Cullen, MD (peer reviewer)
Annenberg Center for Health Sciences
All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.


Unlabeled and Investigational Usage

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.


Copyright Statement

Copyright ©2020 Annenberg Center for Health Sciences